Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia

Details for Australian Patent Application No. 2006259949 (hide)

Owner AstraZeneca AB

Inventors Skjaret, Tore; Lemurell, Malin; Hunegnaw, Fana; Alenfalk, Susanne; Starke, Ingemar; Dahlstrom, Mikael; Lindqvist, Ann-Margret; Karlsson, Staffan

Agent Davies Collison Cave

Pub. Number AU-A-2006259949

PCT Pub. Number WO2006/137782

Priority 0501425-3 20.06.05 SE

Filing date 19 June 2006

Wipo publication date 28 December 2006

International Classifications

C07D 205/08 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137782 Priority application(s): WO2006/137782

7 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006259965-Refrigerator

2006259944-Control system for a pump